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Abstract
Background: Intracranial arterial stenosis (ICAS) is one of the most common causes of stroke, and dyslipidemia was one of
the most common risk factors related to ICAS. However, the correlation between the plasma total cholesterol level (PTC)
and ICAS, especially asymptomatic ICAS (AICAS) is not clear.
Materials and Methods: 5,300 participants were enrolled in this study. The diagnosis of AICAS was made by transcranial
Doppler ultrasonography. The participants were then divided into 5 essentially equal-sized groups based on their PTC levels.
The multivariate logistic regression was used to analyze the correlation between the PTC level and the prevalence of AICAS.
Results: 13.0% of the participants were diagnosed with AICAS. The prevalence of AICAS gradually increased with the
increasing PTC level. After adjusted by the possible confounding factors, the Odds Ratios (OR) of the AICAS prevalence
between the 1st quintile group and the other 4 groups were 1.13, 1.23, 1.63 and 1.75 with 95% confident intervals (CI) of
0.84–1.52, 0.91–1.66, 1.20–2.22 and 1.23–2.47, respectively. The further subgroup analysis revealed that the PTC level was
stronger for males (OR 1.42 95%CI 1.23–1.64), regarding the prevalence of AICAS.
Conclusions: In this large community-based study, the prevalence of AICAS is 13.0%, subjects with higher PTC levels
showed a mild increase in the prevalence of AICAS. The PTC level is an independent risk factor of AICAS. Males seem to be
significantly more vulnerable to the risk of AICAS.
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Introduction
Intracranial arterial stenosis (ICAS) is a common cause of
ischemic stroke. 8.8% of the transient ischemic attack (TIA) and
3.7% of the ischemic stroke (IS) are caused by ICAS [1,2]. The 1-
year recurrence rate of TIA or IS is 23% in patients with ICAS of
more than 70% [3]. In China, ICAS accounts for 33–50% of
stroke and .50% of TIA, that is, the prevalence of ICAS is even
higher than that of the Western population [4–6]. Therefore, it is
important to screen for the risk factors of asymptomatic
intracranial arterial stenosis (AICAS) and prevent the progress of
AICAS through early interventions and decrease the risk of stroke,
even death, in these patients.
The Warfarin-Aspirin Symptomatic Intracranial Disease (WA-
SID) trial found that dyslipidemia was one of the most common
risk factors related to symptomatic ICAS [7], and one of our
studies demonstrated that non-high-density-lipoprotein-cholesterol
and low density cholesterol were associated with AICAS [8].
Whether there is a relationship between the plasma total
cholesterol (PTC) level, which is also an important part in lipid,
and AICAS has not been thoroughly studied. Based on the
Asymptomatic Polyvascular Abnormalities Community (APAC)
study, we sought to analyze the correlation between the PTC level
and the prevalence of AICAS in adult Chinese population.
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Population and study design
The APAC study is a community-based, prospective, long-term
follow-up observational study, to investigate the epidemiology of
asymptomatic polyvascular abnormalities in Chinese adults. It is
part of Kailuan study, which has been described previously [9]. A
sample of 7000 subjects $40 years of age was randomly selected
from Kailuan cohort, using stratified random sampling by age and
sex, based on the data of state census in 2010. The sample size was
calculated based on detection of 7% of event rate with 0.7%
precision, a=0.05. The response rate was assumed to be .80%.
An initial cohort of 5,852 subjects participated the study, and
5,816 completed baseline survey and assessment from June 2010
to June 2011. Among the 5,816 individuals, 376 subjects were
excluded following exclusion criteria (1) history of stroke, transient
ischemic attack, and coronary disease at baseline; (2) presence of
neurologic deficits which was estimated by experienced doctors.
Finally, a total of 5,440 participants were eligible and included in
APAC study. During the baseline survey, all the participants had
undergone questionnaire assessment, clinical, laboratory, and
transcranial Doppler (TCD) examinations. We excluded 65
participants who had incomplete data and 75 participants under
lipid-lowering treatment (34 participants were treated with statins,
3 participants with fibrates, 36 participants with traditional
Chinese medicine/others, 1 participant with statins and fibrates,
another one were treated with statins and traditional Chinese
medicine/others), leaving 3,186 men and 2,114 women in the
analyses. There was no significant difference for the basic
characteristics between the enrolled participants and those who
were excluded (p.0.05, data not shown). The APAC study was
performed according to the guidelines of Helsinki Declaration and
was approved by the Ethics Committees of the Kailuan General
Hospital and Beijing Tiantan Hospital. Written informed consent
was obtained from all participants and approved by the above
ethics committees.
History and physical exam
A questionnaire was used to obtain baseline information,
including age, sex, menopausal status, smoking, family history of
cardiovascular disease, past medical history, such as hypertension,
diabetes, hyperlipidemia, and medications prescribed by physi-
cians. Weight, height and blood pressure (Bp) were measured
during the baseline interview, and body mass index (BMI) was
calculated. Bp was the average of two readings at rest. If the two
measurements differed by more than 5 mm Hg, then an additional
reading was taken, and the average of the three readings was used.
We further categorized the subjects according to different
parameters, i.e. age (,60 years and $60 years), BMI (,30 Kg/
m
2 and $30 Kg/m
2), smoking status (current smoker who smokes
at least one cigarette per day and non-smoker).
Lab test
Blood samples were drawn from the antecubital vein in the
morning after overnight fast. Tubes were centrifuged at 3000 6g
for 10 min at room temperature. After separation, plasma samples
were frozen as rapidly as possible to 280uC for storage until
laboratory determinations were performed. For all participants,
PTC, high density lipoprotein cholesterol (HDL-C), low density
lipoprotein cholesterol (LDL-C), triglycerides (TG) and fasting
blood glucose (FBG) levels were assessed. All the blood variables
were measured using an autoanalyzer (Hitachi 747; Hitachi,
Tokyo, Japan) at the central laboratory of the Kailuan hospital.
The participants were assigned into 5 quintile groups by their PTC
level in ascending order.
Definition of hypertension and diabetes
Hypertension was defined as: (1) previous history of hyperten-
sion diagnosed by a physician; (2) A systolic blood pressure (SBP)
$140 mmHg, and/or a diastolic blood pressure (DBP) $
90 mmHg; or (3) currently underwent antihypertensive treatment
prescribed by a physician. Diabetes mellitus was diagnosed if (1)
the subject was undergoing treatment with insulin or oral
hypoglycemic agents; (2) FBG levels were .7.0 mmol/L; or (3)
previous history of diabetes mellitus which was diagnosed by a
physician.
Transcranial Doppler Ultrasonography (TCD) Examination
TCD is a noninvasive, effective and reliable method to diagnose
intracranial arterial stenosis [10], and it is easy to apply to a large
groups of people, so we selected TCD as the method of choice to
measure arterial stenosis in our study. The TCD exam was
performed by two experienced radiologist using a portable devices
(EME Companion, Nicolet). A diagnosis of AICAS was established
following peak systolic flow velocity (PSV) criteria that were
validated against MR angiography and clinical outcomes [11,12]:
.140 cm/second for the middle cerebral artery (MCA); .
120 cm/second for the anterior cerebral artery (ACA); .
100 cm/second for the posterior cerebral (PCA), vertebral and
basilar arteries; and .120 cm/second for the internal carotid
siphon (SIPH). In addition to the PSV criteria, the participants’
age, disturbance of the echo frequency, turbulence or abnormal
blood flow were also taken into consideration for AICAS diagnosis
[11]. AICAS was diagnosed if at least one of the studied arteries
showed evidence of stenosis. Undetected arteries via both temporal
and orbital window were considered negative for ICAS [11].
Statistical analysis
Statistical analysis was performed using SAS software, ver. 9.1
(SAS Institute, Cary, North Carolina, USA). As all the continuous
variables were in skewed distribution, medians were used for
analysis. Comparison of continuous data was done by Analysis of
Variance (ANOVA) and categorical data was done by Chi-square
Figure 1. The incidence of stenosis in different intracranial
arteries. ACA: anterior cerebral artery; BA: basal artery; MCA: middle
cerebral artery; PCA: posterior cerebral artery; SIPH: siphon carotid
artery; VA: vetebral artery.
doi:10.1371/journal.pone.0101232.g001
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(OR) of the effects of different PTC levels on the presence of
AICAS. The variables adjusted for were age, sex, hypertension,
diabetes, smoking, family history of myocardial infarction (MI) and
stroke, BMI, SBP, DBP, FBG, LDL-C, HDL-C,TG and anti-
hypertension treatment. Additionally, the relationship between
different PTC levels and AICAS was further analysed in
subgroups, such as age, sex, menopause, hypertension, diabetes,
Table 1. Baseline characteristics of participants in different PTC quintile groups.
PTC levels, quintile groups
Q1 Q2 Q3 Q4 Q5 P value
Number 1060 1069 1069 1039 1063
PTC, median(Q1–Q4), mmol/l 3.91(3.67–4.10) 4.49(4.36–4.61) 4.95(4.83–5.07) 5.49(5.34–5.62) 6.32(6.02–6.82) ,0.001
Age, median(Q1–Q4), years 50.51(44.25–60.92) 51.19(44.84–59.44) 52.32(45.73–61.00) 53.39(46.33–61.83) 54.17(47.16–66.10) ,0.001
Women,n(%) 421(39.7) 427(39.9) 420(39.3) 417(40.1) 429(40.4) 0.99
Postmenopausal females,n(%) 157(37.3) 177(41.5) 218(51.9) 240(57.6) 299(69.7) 0.30
Smoking,n(%) 324(30.6) 328(30.7) 351(32.8) 327(31.5) 369(34.7) 0.21
Hypertension,n(%) 466(44.0) 465(43.5) 509(47.6) 527(50.7) 568(53.4) ,0.001
Diabetes,n(%) 91(8.6) 101(9.4) 138(12.9) 136(13.1) 165(15.5) ,0.001
Family history of MI,n,% 49(4.6) 54(5.1) 67(6.3) 67(6.4) 96(9.0) 0.001
Family history of stroke,n(%) 191(18.0) 185(17.3) 179(16.7) 196(18.9) 200(18.8) 0.54
BMI,$30 Kg/m
2,n(%) 462(43.6) 476(44.5) 486(45.5) 499(48.0) 541(50.9) 0.005
SBP, median(Q1–Q4), mmHg 129.33(116.00–140.00) 129.33(116.00–140.00) 130.00(120.00–141.33) 130.00(120.00–143.33) 130.00(120.00–146.00) ,0.001
DBP, median(Q1–Q4), mmHg 80.00(73.75–90.00) 80.00(75.00–90.00) 80.67(76.67–90.00) 80.67(78.67–90.00) 80.67(77.33–90.00) 0.001
FBG, median(Q1–Q4), mmol/L 5.07(4.69–5.51) 5.09(4.73–5.60) 5.20(4.84–5.86) 5.30(4.88–5.87) 5.40(4.98–6.06) ,0.001
LDL-C, median(Q1–Q4), mmol/l 2.08(1.72–2.40) 2.40(2.07–2.74) 2.61(2.30–2.94) 2.85(2.50–3.25) 3.25(2.82–3.78) ,0.001
HDL-C, median(Q1–Q4), mmol/l 1.43(1.22–1.70) 1.50(1.29–1.81) 1.58(1.30–1.86) 1.63(1.35–1.98) 1.75(1.45–2.11) ,0.001
TG, median(Q1–Q4), mmol/l 1.06(0.77–1.51) 1.19(0.86–1.61) 1.24(0.94–1.79) 1.46(1.06–2.10) 1.72(1.14–2.55) ,0.001
Anti-hypertension
treatment,n(%)
174(16.4) 168(15.7) 200(18.7) 229(22.0) 233(21.9) ,0.001
BMI: body mass index; DBP: diastolic blood pressure; FBG: fasting blood glucose; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol;
MI: myocardial infarction; PTC: plasma total cholesterol; SBP: systolic blood pressure; TG: triglycerides.
doi:10.1371/journal.pone.0101232.t001
Figure 2. The prevalence of AICAS in each PTC quintile group. AICAS: asymptomatic intracranial artery stenosis; PTC: plasma total cholesterol.
doi:10.1371/journal.pone.0101232.g002
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0.05, we also added the interaction term into the main logistic
model. All statistical analyses were two-tailed, and a P-value less
than 0.05 was considered statistically significant.
Results
Prevalence of AICAS
In our study, there were 460 subjects (female, 150 subjects,
accounts for 32.6%) who could not be fully evaluated, which
means those have at least one undetected artery. 691 (13.0%) of
the participants were diagnosed of AICAS by TCD. The lesion
affected a variety of the intracranial arteries (Fig. 1). There were
336 participants (6.3%) with stenosis in a single artery, 178
participants (3.4%) in two arteries, and 177 participants (3.3%) in
more than 2 arteries.
Baseline Characteristics
The baseline characteristics of each quintile PTC group were
shown in Table 1. The median and range of the PTC level in
different groups were 3.91 mmol/L (#4.23 mmol/l), 4.49 mmol/l
(4.24–4.72 mol/l), 4.95 mmol/l (4.73–5.19 mmol/l), 5.49 mmol/l
(5.20–5.80 mmol/l) and 6.32 mmol/l ($5.81 mmol/l), respective-
ly. As the PTC levels increased from the 1
st quintile to the 5
th
quintile group, the medians of FBG, LDL-C, HDL-C and TG
level were increased across the quintile PTC groups. Family
history of MI, participants with hypertension and anti-hyperten-
sion treatment, diabetes or obesity were more prevalent in the
groups with higher PTC levels.
Correlation between PTC level and AICAS
In order to show the correlation between PTC level and the
prevalence of AICAS clearly, MCA, ACA and SIPH were
considered as anterior circulation, BA, VA and PCA were
considered as posterior circulation, and Fig. 2 shows that the
prevalence of AICAS in the anterior and posterior circulation
increases with the PTC level rising. PTC level was proven to be an
independent risk factor of AICAS by both un-adjusted and
adjusted logistic regression analysis in our study (crude OR 1.24,
95%CI 1.15–1.34; adjusted OR 1.28, 95% CI 1.14–1.43). After
adjusted by age, sex, hypertension, diabetes, smoking, family
history of MI and stroke, anti-hypertension treatment, BMI, SBP,
DBP, FBG, LDL-C, HDL-C and TG, the prevalences of AICAS
in the 4
th and 5
th quintile group were significantly higher than that
of the 1
st quintile PTC group (4
th vs. 1
st OR 1.63, 95% CI 1.20–
2.22; 5
th vs. 1
st OR 1.75, 95%CI 1.23–2.47). (Table 2 and Fig. 3).
Further analyses of the interaction effects on the association
between PTC levels and the prevalence of AICAS showed that
there was a significant difference between men and women (P for
Figure 3. ORs and 95%CIs for AICAS between different PTC quintile groups. OR: odd ratio; CI: confidential interval; AICAS: asymptomatic
intracranial artery stenosis; PTC: plasma total cholesterol.
doi:10.1371/journal.pone.0101232.g003
Table 2. Odd ratios (OR) for AICAS between different PTC quintile groups.
PTC levels
Q1 Q2 Q3 Q4 Q5 Continuous Scale
AICAS N(%) 108(10.2) 113(10.6) 132(12.3) 163(15.7) 175(16.5) 691(13.0)
Crude OR (95%CI) 1 1.04(0.79–1.38) 1.24(0.95–1.63) 1.64(1.27–2.13) 1.74(1.34–2.25) 1.24(1.15–1.34)
Model 1 OR (95%CI) 1 1.07(0.81–1.42) 1.24(0.94–1.63) 1.61(1.24–2.10) 1.62(1.25–2.10) 1.19(1.10–1.29)
Model 2 OR, 95%CI 1 1.13(0.84–1.52) 1.23(0.91–1.66) 1.63(1.20–2.22)* 1.75(1.23–2.47)* 1.28(1.14–1.43)**
*P ,0.05;
** P,0.001.
95%CI: 95% confidence interval; AICAS: asymptomatic intracranial artery stenosis; MI: myocardial infarction; PTC: plasma total cholesterol.
PTC levels: Q1#4.23 mmol/l, Q2 4.24–4.72 mol/l, Q3 4.73–5.19 mmol/l, Q4 5.20–5.80 mmol/l and Q5$5.81 mmol/l.
Model 1: adjusted for age, sex;
Model 2: adjusted for age, sex, hypertension, diabetes, smoking, family history of myocardial infarction and stroke, BMI, SBP, DBP, FBG, LDL-C, HDL-C, TG, anti-
hypertension treatment and sex*PTC.
doi:10.1371/journal.pone.0101232.t002
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significant in men only (P,0.05), Our results indicated that in
men, the prevalence of AICAS was significantly increased with
increasing PTC levels (OR 1.42, 95%CI: 1.23–1.64), especially
when PTC $4.73 mmol/L (Q3 OR 1.70 95%CI 1.14–2.55; Q4
OR 2.41 95%CI 1.59–3.64; Q5 OR 3.10 95%CI 1.95–4.91). In
contrast, in women, PTC levels were not an independent indicator
for the presence of AICAS (OR 1.17, 95%CI: 0.97–1.42). When
other baseline characteristics (including age, menopausal status,
hypertension, diabetes, smoking and BMI) were evaluated, the
presence or absence of these indicators did not influence the
association between PTC levels and the prevalence of AICAS
(P=0.32, 0.42, 0.94, 0.46, 0.16 and 0.15 respectively), although
the OR values for some subgroups were significant (Table 3 and
Fig. 4).
Discussions
ICAS prevention is considered one of the most important
measures to reduce the risk of cerbral vascular accident. Previous
studies have shown that ICAS was closely related to the
occurrence of ischemic stroke [13]. In a group of participants
who were followed up for a median of 18 months, researchers
found that 18.6% of all symptomatic ICAS patients would
eventually develop ischemic stroke and 13.2% of the ischemic
stroke patients were caused by AICAS [13]. Similar results were
also seen in Chinese population. One study contained 705 Chinese
patients with acute ischemic stroke and followed up for 42 months,
eventually it was found that the annual recurrence rates of stroke
caused by ICAS in the 1
st and 2
nd year during follow-up were
17.1% and 8.6%, respectively [6].
Since the PTC level had been shown to be positively correlated
with the incidence of ischemic stroke [14], we sought to investigate
the relationship between the PTC level and the prevalence of
AICAS in this study. Our results showed that the risk of AICAS
was related to the PTC level. It has been proven that dyslipidemia
was strongly associated with the severity of ICAS [7,15]. In the
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID)
trial, dyslipidemia was found to be one of the most common risk
factors related to severe ICAS [7]. Investigation in a group of
1,471 TIA and minor stroke patients revealed that the low HDL-
C level coupled with high TG level was strongly related to the
occurrence of symptomatic ICAS and the risk of early stroke was
significantly higher in the patients with hyperlipidemia than in the
patients without this disorder [15]. Our previous study showed
that non-HDL was associated with ICAS [8], and concentrations
of apolipoprotein E [16] and lipoprotein(a) [17] were also found to
be risk factors for ICAS. However, current evidences of the
correlation between PTC and ICAS, especially with AICAS were
limited.
The prevalence of AICAS was 11.8% (250 cases) in females and
13.8% (441 cases) in males in our study. We also found that the
elevated PTC level was significantly related to the risk of AICAS in
male participants but not in females. This finding was in
agreement with the results from previous studies [2,18]. Several
factors might contribute to this phenomenon. First, sex hormones
might play an important role in this process [18]. Cholesterol is an
important precursor for the synthesis of steroid hormones,
including the sex hormones progesterone, estrogens and testoster-
one. There were evidences shown that the hormone replacement
therapy in postmenopausal women could significantly decrease the
risk of atherosclerosis [19]. There were 1,091 (51.6%) postmen-
opausal females in our study. The elevated PTC level might have
some protective effect to prevent them from developing athero-
sclerosis, which is the most important cause of ICAS. Second, the
efficacy of the TCD decreased with age and the trend were more
commonly seen in women than in men [20]. Since all the
participants with a poor temporal window reading were consid-
ered without AICAS, this might result in disproportionally
underestimating the prevalence of AICAS in the females.
However, in our population, there is no significant difference of
Figure 4. ORs and 95%CIs for AICAS of PTC level in different subgroups. # additionally adjusted for menopausal status. OR: odd ratio; CI:
confidential interval; AICAS: asymptomatic intracranial artery stenosis; PTC: plasma total cholesterol.
doi:10.1371/journal.pone.0101232.g004
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PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e101232subjects with poor temporal window between male and female in
age,60 y and $60 y groups (data not shown). The aim of our
large-scale cross-sectional study was to investigate the possible
correlation between PTC level and AICAS. There were some
limitations in our study despite of the careful study design. First, all
participants with poor temporal window reading in TCD were
considered non-ICAS in our study. This might result in a
significantly underestimated prevalence of ICAS. Second, all the
participants were from area and same ethnic group. This would
limit the application of the findings to a population with broader
geographic and ethnic diversity. Third, although TCD has been
regarded as a noninvasive and convenient screening method to
diagnose ICAS, it is not as accurate as DSA for determining ICAS
[21]. Despite these limitations, our study was so far the first large-
scale clinic trial to our knowledge that investigate the correlation
between PTC level and AICAS. We also excluded the patients
who were taking antihyperlipidemic medicine at the recruitment
to eliminate the drug interference to the baseline PTC level.
Conclusions
PTC level was an independent risk factor for the occurrence of
AICAS, especially in males. Further studies are needed to provide
us more information on its treatment and prognosis.
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